Lidocaine for cystitis, interstitial

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Feb 2023: Trial registered, NCT05737121
  2. 22 May 2023: Trial started, NCT05737121

The trials

NCT05737121: Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

State
Under way
Phase
Phase 2
People
120 planned
Started
22 May 2023
Primary completion
Jun 2026
Arms
Lidocaine
Results
None posted
  1. 21 Feb 2023: Trial registered
  2. 22 May 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Alphacaine, Bondlido, Dentipatch, Fortacin component lidocaine, Lidoderm, Lidocaine (drug), Paracervical block- Lidocaine without epinephrine, Ztlido.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.